Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Net Income (2016 - 2025)

Rockwell Medical's Net Income history spans 16 years, with the latest figure at -$640000.0 for Q4 2025.

  • For Q4 2025, Net Income rose 17.84% year-over-year to -$640000.0; the TTM value through Dec 2025 reached -$5.6 million, down 907.4%, while the annual FY2025 figure was -$5.6 million, 907.4% down from the prior year.
  • Net Income reached -$640000.0 in Q4 2025 per RMTI's latest filing, up from -$1.8 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of $1.7 million in Q3 2024 to a low of -$8.9 million in Q4 2021.
  • Average Net Income over 5 years is -$3.3 million, with a median of -$2.0 million recorded in 2023.
  • Peak YoY movement for Net Income: skyrocketed 179.54% in 2024, then plummeted 632.88% in 2025.
  • A 5-year view of Net Income shows it stood at -$8.9 million in 2021, then surged by 73.59% to -$2.4 million in 2022, then skyrocketed by 31.71% to -$1.6 million in 2023, then surged by 51.7% to -$779000.0 in 2024, then rose by 17.84% to -$640000.0 in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Net Income are -$640000.0 (Q4 2025), -$1.8 million (Q3 2025), and -$1.6 million (Q2 2025).